Radin
Indication
- Active duodenal ulcer
- Pathological gastric ulcer
- Reflux esophagitis
- Prevention of peptic ulcer relapse
- Zollinger-Ellison syndrome
Composition
Ranitidine HCl 25 mg
Package
5 ampoules of 2 ml
Dosage Forms
ATC Classification
A02B
Warning
Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Safe if Prescribed
This item is safe for use while operating heavy machinery.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Caution
This item may not be safe for use during lactation. Use with caution and after consultation with your doctor.
Dosage
0 to 18 Years Old
Safety and efficacy in pediatrics has not been established.
18 Years Old and Above
Intramuscular (IM) injection:
- 50 mg (no dilution necessary) every 6-8 hours.
Intravenous (IV) injection: intermittent.
- Intermittent bolus: 50 mg (2 ml) every 6-8 hours. Dilute ranitidine injection 50 mg in 0.9% sodium chloride solution or other compatible IV solution to a concentration not greater than 2.5 mg/ml (total volume of 20 ml). Rate of injection should not exceed 4 ml/minutes (for 5 minutes).
- Intermittent infusion: 50 mg (2 ml) every 6-8 hours. Dilute ranitidine injection 50 mg in 100 mL of 5% dextrose solution or other compatible IV solution to a concentration not greater than 0.5 mg/ml (total volume of 100 ml). Rate of infusion should not exceed 5-7 ml/minutes (for 15-20 minutes).
- Continuous IV infusion: Dilute ranitidine 150 mg in 250 ml of 5% dextrose solution or other compatible IV solution and rate of infusion is 6.25 mg/hour for 24 hours.
For Zollinger-Ellison syndrome or other pathological hypersecretory conditions, ranitidine injection should be diluted to a concentration not greater than 2.5 mg/ml with 5% dextrose solution or other compatible IV solution. Initial infusion rate is 1 mg/kg body weight/hour and should be adjusted to patient’s condition.